Quantification of BIM mRNA In Circulating Tumor Cells Of Osimertinib-treated Patients with EGFR Mutation-positive Lung Cancer

被引：0
|
作者：
Isobe, K. [1 ]
Kobayashi, H. [1 ]
Isshiki, T. [1 ]
Sakamoto, S. [1 ]
Takai, Y. [1 ]
Tomida, T. [2 ]
Adachi-Akahane, S. [2 ]
Kishi, K. [1 ]
机构：
[1] Toho Univ, Sch Med, Dept Resp Med, Tokyo, Japan
[2] Toho Univ, Sch Med, Dept Physiol, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P34.07
引用
收藏
页码：S417 / S418
页数：2
相关论文
共 50 条
  • [1] Quantification of BIM mRNA in circulating tumor cells of osimertinib-treated patients with EGFR mutation-positive lung cancer
    Isobe, Kazutoshi
    Yoshizawa, Takahiro
    Sekiya, Muneyuki
    Miyoshi, Shion
    Nakamura, Yasuhiko
    Urabe, Naohisa
    Isshiki, Takuma
    Sakamoto, Susumu
    Takai, Yujiro
    Tomida, Taichiro
    Adachi-Akahane, Satomi
    Iyoda, Akira
    Homma, Sakae
    Kishi, Kazuma
    RESPIRATORY INVESTIGATION, 2021, 59 (04) : 535 - 544
  • [2] Development of Liposomal Vesicles for Osimertinib Delivery to EGFR Mutation-Positive Lung Cancer Cells
    Skupin-Mrugalska, Paulina
    Minko, Tamara
    PHARMACEUTICS, 2020, 12 (10) : 1 - 17
  • [3] Osimertinib for treating Patients with EGFR Mutation-Positive non-small cell Lung Cancer
    Meinrenken, Susanne
    PNEUMOLOGIE, 2018, 72 (04): : 246 - 246
  • [4] Osimertinib for the treatment of patients with EGFR mutation-positive non-small cell lung cancer
    Alsharedi, M.
    Bukamur, H.
    Elhamdani, A.
    DRUGS OF TODAY, 2018, 54 (06) : 369 - 379
  • [5] Osimertinib for the Treatment of EGFR Mutation-Positive Lung Adenocarcinoma Complicated With Dermatomyositis
    Yamasaki, Masahiro
    Matsumoto, Naoko
    Nakano, Shota
    Kawamoto, Kazuma
    Taniwaki, Masaya
    Izumi, Yusuke
    Otohara, Masaya
    Nabeshima, Shinji
    Ohashi, Nobuyuki
    Hattori, Noboru
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (12): : 822 - 823
  • [6] ANALYSIS OF CIRCULATING TUMOR EGFR-DNA IN PLASMA DURING EGFR-TKI THERAPY OF EGFR MUTATION-POSITIVE LUNG CANCER PATIENTS
    Uchida, J.
    Niki, T.
    Okuyama, T.
    Nishino, K.
    Kumagai, T.
    Akazawa, Y.
    Imamura, F.
    ANNALS OF ONCOLOGY, 2013, 24
  • [7] Efficacy of afatinib following osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
    Tamura, Tomohiro
    Okubo, Hatsumi
    Yamada, Yutaka
    Kikkawa, Yasuko
    Yamaguchi, Shozaburo
    Hashimoto, Ikuta
    Kaburagi, Takayuki
    ANNALS OF ONCOLOGY, 2021, 32 : S335 - S335
  • [8] Outcome of osimertinib-treated patients with epidermal growth factor receptor mutation-positive nonsmall cell lung cancer requiring dose reduction: a secondary analysis of the Reiwa study
    Awano, Nobuyasu
    Yoh, Kiyotaka
    Usui, Kazuhiro
    Hosomi, Yukio
    Kishi, Kazuma
    Naka, Go
    Watanabe, Kageaki
    Tamano, Shu
    Uemura, Kohei
    Kunitoh, Hideo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024,
  • [9] Analysis of 148 cases of EGFR mutation-positive lung cancer patients
    Abe, Yuko
    Tanio, Yoshiro
    Shirai, Yuya
    Mitui, Yuichi
    Ogawa, Koichi
    Akazawa, Yuki
    Ueno, Kiyonobu
    Oomori, Kenichi
    Shimamoto, Shigetoshi
    Fushimi, Hiroaki
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression
    Moiseyenko, Fedor V.
    Moiseyenko, Vladimir M.
    Aleksakhina, Svetlana N.
    Chubenko, Vyacheslav A.
    Volkov, Nikita M.
    Kozyreva, Kseniya S.
    Kramchaninov, Michail M.
    Zhuravlev, Alexandr S.
    Shelekhova, Kseniya V.
    Ivantsov, Alexandr O.
    Venina, Aigul R.
    Preobrazhenskaya, Elena V.
    Mitiushkina, Natalia V.
    Iyevleva, Aglaya G.
    Imyanitov, Evgeny N.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (10) : 605 - +
12345